Status | Study |
Not yet recruiting |
Study Name: Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF Condition: Exudative Age Related Macular Degeneration Date: 2017-02-24 Interventions: Drug: Ranibizumab Injection [Lucentis] intravitreal injection |
Not yet recruiting |
Study Name: Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination Condition: Papilledema Associated With Increased Intracranial Pressure Date: 2016-12-05 Interventions: Device: Point of care ocular ultrasound |
Not yet recruiting |
Study Name: OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension Condition: Pediatric Idiopathic Intracranial Hypertension Date: 2016-01-24 Interventions: Other: OCT Imaging |
Completed |
Study Name: aICP in Glaucoma and Papilledema Condition: Open-angle Glaucoma Papilledema Date: 2015-03-23 Interventions: Device: Non-invasive ICP measurement (Vittamed 305) The non-invasive method is based on two-depth TCD te |
Recruiting |
Study Name: Antiacne Medications Pseudotumor Cerebri Condition: Optic Disc Swelling Date: 2014-04-07 Interventions: Other: Retinal nerve fibre layer measurement Measurement of retinal nerve fibre layer thickness using op |
Completed |
Study Name: Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. Condition: Idiopathic Intracranial Hypertension Date: 2013-12-16 Interventions: Drug: AZD4017 Other Name: 11b- |
Recruiting |
Study Name: Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery Condition: Cataract Retinal Edema Inflammation Date: 2013-04-16 Interventions: Drug: Prolensa (bromfenac 0.07%) |
Available |
Study Name: A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema Condition: Diabetic Macular Edema Date: 2011-12-05 Interventions: Drug: Macugen (Pegaptanib Sodium) Pegaptanib sodium drug s |
Completed |
Study Name: Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study Condition: Diabetic Macular Edema Date: 2011-12-02 Interventions: Drug: Macugen® pegaptanib sodium Patients assigned to |
Completed |
Study Name: Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting Condition: Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Wet Age Date: 2011-03-17 Interventions: Drug: Ranibizumab Other: Ranibizumab |